These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18491535)

  • 1. Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.
    Khan S; Chen ZJ; Nath R
    Med Phys; 2008 Apr; 35(4):1403-6. PubMed ID: 18491535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
    Chen ZJ; Bongiorni P; Nath R
    Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
    Abboud F; Scalliet P; Vynckier S
    Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
    Sadeghi M; Raisali G; Hosseini SH; Shavar A
    Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
    Monroe JI; Williamson JF
    Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic evaluation of the dose-rate constant determined by photon spectrometry for 21 different models of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Phys Med Biol; 2010 Oct; 55(20):6089-104. PubMed ID: 20871136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
    J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
    Sowards KT
    J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photon spectrometry for the determination of the dose-rate constant of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Med Phys; 2007 Apr; 34(4):1412-30. PubMed ID: 17500473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
    Nath R; Yue N; Roa E
    Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
    Li Z; Palta JR; Fan JJ
    Med Phys; 2000 May; 27(5):1108-12. PubMed ID: 10841416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
    Rivard MJ; Melhus CS; Kirk BL
    Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental characterization of the dosimetric properties of a newly designed I-Seed model AgX100 ¹²⁵I interstitial brachytherapy source.
    Chen Z; Bongiorni P; Nath R
    Brachytherapy; 2012; 11(6):476-82. PubMed ID: 22104352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
    Sadeghi M; Hosseini SH; Raisali G
    Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.